Super Bowl 59 commercials are proving to be a popular platform for tech companies like Google to advertise their latest AI-powered products.

Which explains once again why Amazon and Google, so prominent in the here and now, are operating as though they're startups.

They "are the spontaneous and delightful changes made to the Google logo," Google said. "They celebrate a range of local and international topics ranging from holidays and anniversaries ...

Google is following the Trump administration’s lead on purging diversity, equity and inclusion efforts, cutting mentions of DEI from its annual report and scrapping its goal of hiring applicants ...

Alphabet Inc.’s Google removed a passage from its artificial intelligence principles that pledged to avoid using the technology in potentially harmful applications, such as weapons. The company ...

Building on the company’s work to get on the big screen in every living room, Google TV delivers a new experience that’s remote-centric and built around keeping all of your content in one place.

Supernus (SUPN) Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, approved ONAPGO injection, formerly known as SPN-830, as the first and only subcutaneous apomorphine ...

Below we have compiled a full list of Google algorithm launches, updates, and refreshes that have rolled out over the years, as well as links to resources for SEO professionals who want to ...

There was a big Google presence at the Galaxy S25 launch event this morning. Google is now specifically telling Pixel 9 owners (and prospective buyers) about what new Gemini AI features they are ...

Investors might want to bet on Supernus Pharmaceuticals (SUPN), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in ...

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Supernus Pharmaceuticals' ONAPGO for Parkinson’s Disease received FDA approval, providing a basis for optimism despite past regulatory challenges with SPN-830. The company is methodically ...